The transitional experience of women with newly diagnosed breast cancer

The aim of the study was to provide insights into the transitional experience of women newly diagnosed with breast cancer progressing to their primary treatment. The psychosocial impact of patients in the recovery phase after breast cancer treatment has been investigated in recent years, however, little is known about the transition experience and psychosocial needs of Danish breast cancer patients during the phase of transition from diagnosis to treatment. This study employed a qualitative descriptive design with data collection including 12 semi-structured interviews with women undergoing radiation-or chemotherapy treatment. The transcribed interviews were analysed which identified five main themes; 1) Uncertainty, 2) Sense of powerlessness, 3) Sustaining normality, 4) Worrying about the future, 5) Fortunate only having radiotherapy. Understanding care needs of women in transition, from diagnosis to treatment, and how it impacts on their lives, is essential to enable health professionals to tailor individualized care. Early support is critical to ensure that women understand step-by-step what is involved in the treatment and care and thereby to assist them towards a positive psychosocial trajectory

Phagocytosis tests with M1 and M3 strains.

<p>(<b>A</b>) Suspensions of the bacterial strains indicated were analyzed for ability to bind human FH. After incubation of a bacterial suspension with pure FH (50 µg/ml), the bacteria were washed twice and bound protein was eluted and analyzed by western blot, employing anti-FH for detection. The analysis included wild type M5, M1 and M3 strains and their M-negative mutants (ΔM5, ΔM1 and ΔM3, respectively). Pure FH was included as a control in the blot (right). (<b>B</b>) Phagocytosis assay in whole human blood with M1 and M3 strains, and M-negative mutants, as indicated. MF, multiplication factor.</p